Clincosm LogoSign in Get a demo

fgfr2 gene mutation

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation Trial in United States (TT-00420)

Recruiting
  • Cholangiocarcinoma
  • +4 more
  • Anchorage, Alaska
  • +16 more
Jan 3, 2023

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life

Active, not recruiting
  • FGFR1 Gene Amplification
  • +18 more
  • Scottsdale, Arizona
  • +5 more
Oct 18, 2022

Advanced Cholangiocarcinoma, FGFR2 Gene Mutation Trial in Worldwide (BGJ398, Gemcitabine, Cisplatin)

Active, not recruiting
  • Advanced Cholangiocarcinoma
  • FGFR2 Gene Mutation
  • Gilbert, Arizona
  • +115 more
Oct 17, 2022

Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Recruiting
  • Bladder Cancer
  • +12 more
  • Raleigh, North Carolina
    xCures Virtual Site
Sep 20, 2021

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification Trial in Canada, United States (Docetaxel, FGFR

Completed
Has Results
  • FGFR1 Gene Amplification
  • +7 more
  • Birmingham, Alabama
  • +1083 more
May 25, 2021

FGFR Gene Amplification, FGFR1 Gene Amplification, FGFR2 Gene Amplification Trial in Chicago (BGJ398)

Terminated
Has Results
  • FGFR Gene Amplification
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 9, 2019